Miller David C, Saigal Christopher S, Banerjee Mousumi, Hanley Jan, Litwin Mark S
Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, California 90095-1738, USA.
Cancer. 2008 Apr 15;112(8):1708-17. doi: 10.1002/cncr.23372.
Despite their potential benefits to patients with kidney cancer, the adoption of partial nephrectomy and laparoscopy has been gradual and asymmetric. To clarify whether this trend reflects differences in kidney cancer patients or differences in surgeon practice styles, the authors compared the magnitude of surgeon-attributable variance in the use of partial nephrectomy and laparoscopic radical nephrectomy with that attributable to patient and tumor characteristics.
By using linked Surveillance, Epidemiology, and End Results-Medicare data, the authors identified a cohort of 5483 Medicare beneficiaries who underwent surgery for kidney cancer between 1997 and 2002. Two primary outcomes were defined: 1) the use of partial nephrectomy and (2) the use of laparoscopy among patients undergoing radical nephrectomy. By using multilevel models, surgeon- and patient-level contributions to observed variations in the use of partial nephrectomy and laparoscopic radical nephrectomy were estimated.
Of the 5483 cases identified, 611 (11.1%) underwent partial nephrectomy (43 performed laparoscopically), and 4872 (88.9%) underwent radical nephrectomy (515 performed laparoscopically). After adjusting for patient demographics, comorbidity, tumor size, and surgeon volume, the surgeon-attributable variance was 18.1% for partial nephrectomy and 37.4% for laparoscopy. For both outcomes, the percentage of total variance attributable to surgeon factors was consistently higher than that attributable to patient characteristics.
For many patients with kidney cancer, the surgery provided depends more on their surgeon's practice style than on the characteristics of the patient and his or her disease. Consequently, dismantling barriers to surgeon adoption of partial nephrectomy and laparoscopy is an important step toward improving the quality of care for patients with early-stage kidney cancer.
尽管部分肾切除术和腹腔镜手术对肾癌患者有潜在益处,但其采用过程一直较为缓慢且不均衡。为明确这种趋势是反映了肾癌患者之间的差异还是外科医生手术方式的不同,作者比较了部分肾切除术和腹腔镜根治性肾切除术使用中外科医生导致的差异程度与患者及肿瘤特征导致的差异程度。
通过使用关联的监测、流行病学和最终结果 - 医疗保险数据,作者确定了一组5483名在1997年至2002年间接受肾癌手术的医疗保险受益人。定义了两个主要结局:1)部分肾切除术的使用情况,以及(2)根治性肾切除术中腹腔镜手术的使用情况。通过使用多级模型,估计了外科医生和患者层面因素对部分肾切除术和腹腔镜根治性肾切除术使用情况观察到的差异的贡献。
在确定的5483例病例中,611例(11.1%)接受了部分肾切除术(其中43例为腹腔镜手术),4872例(88.9%)接受了根治性肾切除术(其中515例为腹腔镜手术)。在调整了患者人口统计学、合并症、肿瘤大小和外科医生手术量后,部分肾切除术的外科医生导致的差异为18.1%,腹腔镜手术为37.4%。对于这两个结局,外科医生因素导致的总差异百分比始终高于患者特征导致的百分比。
对于许多肾癌患者,所接受的手术更多地取决于其外科医生的手术方式,而非患者及其疾病的特征。因此,消除外科医生采用部分肾切除术和腹腔镜手术的障碍是提高早期肾癌患者护理质量的重要一步。